TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.

Christian Buske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.